Last 12 months
Inside the activity.
0 purchase rows · 27 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 7 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 10 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 2 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 16, 2026 Filed Mar 17, 2026 21:35 UTC |
KASINGER JAMES R.General Counsel and Secretary
|
SaleCommon Shares | 3,450 | $48.26 | $166,497.00 |
DisclosureSEC source: 0001193125-26-111281 · ownership.xml · nonDerivative · entry 2 KASINGER JAMES R. · CIK 0001708172 · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 91,240 F3 · shares: Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person. Read SEC document |
| March 16, 2026 Filed Mar 17, 2026 21:35 UTC |
Kulkarni SamarthDirector · Chief Executive Officer
|
SaleCommon Shares | 10,349 | $48.26 | $499,442.74 |
DisclosureSEC source: 0001193125-26-111278 · ownership.xml · nonDerivative · entry 2 Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 245,834 F3 · shares: Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person. Read SEC document |
| March 14, 2026 Filed Mar 17, 2026 21:37 UTC |
Patel NaimishChief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 8,125 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-111286 · ownership.xml · derivative · entry 3 Patel Naimish · CIK 0002021679 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,375 Underlying: Common Shares · 8,125 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. F1 · kind: These shares remain subject to a lock-up agreement with the underwriters of the Issuer's offering of convertible senior notes due 2031. F2 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. F5 · derivative.exercise_date: This restricted stock unit award was granted on March 14, 2025 with respect to 32,500 Common Shares, with (i) one quarter of the shares vesting on March 14, 2026, (ii) one quarter of the shares vesting on March 14, 2027, (iii) one quarter of the shares vesting on March 14, 2028, and (iv) one quarter of the shares vesting on March 14, 2029. F5 · derivative.expiration_date: This restricted stock unit award was granted on March 14, 2025 with respect to 32,500 Common Shares, with (i) one quarter of the shares vesting on March 14, 2026, (ii) one quarter of the shares vesting on March 14, 2027, (iii) one quarter of the shares vesting on March 14, 2028, and (iv) one quarter of the shares vesting on March 14, 2029. Read SEC document |
| March 14, 2026 Filed Mar 17, 2026 21:37 UTC |
Patel NaimishChief Medical Officer
|
Exercise / conversionCommon Shares | 8,125 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-111286 · ownership.xml · nonDerivative · entry 1 Patel Naimish · CIK 0002021679 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,293 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares remain subject to a lock-up agreement with the underwriters of the Issuer's offering of convertible senior notes due 2031. F2 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. F3 · balance_after: Includes 592 shares acquired under the CRISPR Therapeutics AG 2016 Employee Stock Purchase Plan. Read SEC document |
| March 14, 2026 Filed Mar 17, 2026 21:37 UTC |
Prasad RajuChief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 6,875 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-111284 · ownership.xml · derivative · entry 7 Prasad Raju · CIK 0001968317 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,625 Underlying: Common Shares · 6,875 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. F1 · kind: These shares remain subject to a lock-up agreement with the underwriters of the Issuer's offering of convertible senior notes due 2031. F2 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. F6 · derivative.exercise_date: This restricted stock unit award was granted on March 14, 2025 with respect to 27,500 Common Shares, with (i) one quarter of the shares vesting on March 14, 2026, (ii) one quarter of the shares vesting on March 14, 2027, (iii) one quarter of the shares vesting on March 14, 2028, and (iv) one quarter of the shares vesting on March 14, 2029. F6 · derivative.expiration_date: This restricted stock unit award was granted on March 14, 2025 with respect to 27,500 Common Shares, with (i) one quarter of the shares vesting on March 14, 2026, (ii) one quarter of the shares vesting on March 14, 2027, (iii) one quarter of the shares vesting on March 14, 2028, and (iv) one quarter of the shares vesting on March 14, 2029. Read SEC document |
| March 14, 2026 Filed Mar 17, 2026 21:37 UTC |
Prasad RajuChief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 10,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-111284 · ownership.xml · derivative · entry 6 Prasad Raju · CIK 0001968317 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Shares · 10,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. F1 · kind: These shares remain subject to a lock-up agreement with the underwriters of the Issuer's offering of convertible senior notes due 2031. F2 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. F5 · derivative.exercise_date: This restricted stock unit award was granted on March 14, 2023 with respect to 40,000 Common Shares, with (i) one quarter of the shares vesting on March 14, 2024, (ii) one quarter of the shares vesting on March 14, 2025, (iii) one quarter of the shares vesting on March 14, 2026, and (iv) one quarter of the shares vesting on March 14, 2027. F5 · derivative.expiration_date: This restricted stock unit award was granted on March 14, 2023 with respect to 40,000 Common Shares, with (i) one quarter of the shares vesting on March 14, 2024, (ii) one quarter of the shares vesting on March 14, 2025, (iii) one quarter of the shares vesting on March 14, 2026, and (iv) one quarter of the shares vesting on March 14, 2027. Read SEC document |
| March 14, 2026 Filed Mar 17, 2026 21:37 UTC |
Prasad RajuChief Financial Officer
|
Exercise / conversionCommon Shares | 6,875 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-111284 · ownership.xml · nonDerivative · entry 2 Prasad Raju · CIK 0001968317 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,642 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares remain subject to a lock-up agreement with the underwriters of the Issuer's offering of convertible senior notes due 2031. F2 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. Read SEC document |
| March 14, 2026 Filed Mar 17, 2026 21:37 UTC |
Prasad RajuChief Financial Officer
|
Exercise / conversionCommon Shares | 10,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-111284 · ownership.xml · nonDerivative · entry 1 Prasad Raju · CIK 0001968317 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,767 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares remain subject to a lock-up agreement with the underwriters of the Issuer's offering of convertible senior notes due 2031. F2 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. Read SEC document |
| March 14, 2026 Filed Mar 17, 2026 21:35 UTC |
KASINGER JAMES R.General Counsel and Secretary
|
Exercise / conversionRestricted Stock Units · Derivative | 6,875 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-111281 · ownership.xml · derivative · entry 3 KASINGER JAMES R. · CIK 0001708172 · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,625 Underlying: Common Shares · 6,875 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. F1 · kind: These shares remain subject to a lock-up agreement with the underwriters of the Issuer's offering of convertible senior notes due 2031. F2 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. F4 · derivative.exercise_date: This restricted stock unit award was granted on March 14, 2025 with respect to 27,500 Common Shares, with (i) one quarter of the shares vesting on March 14, 2026, (ii) one quarter of the shares vesting on March 14, 2027, (iii) one quarter of the shares vesting on March 14, 2028, and (iv) one quarter of the shares vesting on March 14, 2029. F4 · derivative.expiration_date: This restricted stock unit award was granted on March 14, 2025 with respect to 27,500 Common Shares, with (i) one quarter of the shares vesting on March 14, 2026, (ii) one quarter of the shares vesting on March 14, 2027, (iii) one quarter of the shares vesting on March 14, 2028, and (iv) one quarter of the shares vesting on March 14, 2029. Read SEC document |
| March 14, 2026 Filed Mar 17, 2026 21:35 UTC |
KASINGER JAMES R.General Counsel and Secretary
|
Exercise / conversionCommon Shares | 6,875 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-111281 · ownership.xml · nonDerivative · entry 1 KASINGER JAMES R. · CIK 0001708172 · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,690 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares remain subject to a lock-up agreement with the underwriters of the Issuer's offering of convertible senior notes due 2031. F2 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. Read SEC document |
| March 14, 2026 Filed Mar 17, 2026 21:35 UTC |
Kulkarni SamarthDirector · Chief Executive Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 20,625 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-111278 · ownership.xml · derivative · entry 3 Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,875 Underlying: Common Shares · 20,625 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. F1 · kind: These shares remain subject to a lock-up agreement with the underwriters of the Issuer's offering of convertible senior notes due 2031. F2 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. F4 · derivative.exercise_date: This restricted stock unit award was granted on March 14, 2025 with respect to 82,500 Common Shares, with (i) one quarter of the shares vesting on March 14, 2026, (ii) one quarter of the shares vesting on March 14, 2027, (iii) one quarter of the shares vesting on March 14, 2028, and (iv) one quarter of the shares vesting on March 14, 2029. F4 · derivative.expiration_date: This restricted stock unit award was granted on March 14, 2025 with respect to 82,500 Common Shares, with (i) one quarter of the shares vesting on March 14, 2026, (ii) one quarter of the shares vesting on March 14, 2027, (iii) one quarter of the shares vesting on March 14, 2028, and (iv) one quarter of the shares vesting on March 14, 2029. Read SEC document |
| March 14, 2026 Filed Mar 17, 2026 21:35 UTC |
Kulkarni SamarthDirector · Chief Executive Officer
|
Exercise / conversionCommon Shares | 20,625 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-111278 · ownership.xml · nonDerivative · entry 1 Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 256,183 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares remain subject to a lock-up agreement with the underwriters of the Issuer's offering of convertible senior notes due 2031. F2 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. Read SEC document |
| March 11, 2026 Filed Mar 12, 2026 21:35 UTC |
KASINGER JAMES R.General Counsel and Secretary
|
SaleCommon Shares | 2,800 | $52.80 | $147,840.00 |
DisclosureSEC source: 0001193125-26-104481 · ownership.xml · nonDerivative · entry 2 KASINGER JAMES R. · CIK 0001708172 · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,815 F3 · shares: Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person. Read SEC document |
| March 11, 2026 Filed Mar 12, 2026 21:35 UTC |
Kulkarni SamarthDirector · Chief Executive Officer
|
SaleCommon Shares | 9,798 | $52.80 | $517,334.40 |
DisclosureSEC source: 0001193125-26-104480 · ownership.xml · nonDerivative · entry 2 Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 235,558 F3 · shares: Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 21:35 UTC |
KASINGER JAMES R.General Counsel and Secretary
|
Exercise / conversionRestricted Stock Units · Derivative | 5,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-104481 · ownership.xml · derivative · entry 3 KASINGER JAMES R. · CIK 0001708172 · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,500 Underlying: Common Shares · 5,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. F1 · kind: These shares remain subject to a lock-up agreement with the underwriters of the Issuer's offering of convertible senior notes due 2031. F2 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. F4 · derivative.exercise_date: This restricted stock unit award was granted on March 10, 2023 with respect to 22,000 Common Shares, with (i) one quarter of the shares vesting on March 10, 2024, (ii) one quarter of the shares vesting on March 10, 2025, (iii) one quarter of the shares vesting on March 10, 2026, and (iv) one quarter of the shares vesting on March 10, 2027. F4 · derivative.expiration_date: This restricted stock unit award was granted on March 10, 2023 with respect to 22,000 Common Shares, with (i) one quarter of the shares vesting on March 10, 2024, (ii) one quarter of the shares vesting on March 10, 2025, (iii) one quarter of the shares vesting on March 10, 2026, and (iv) one quarter of the shares vesting on March 10, 2027. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 21:35 UTC |
KASINGER JAMES R.General Counsel and Secretary
|
Exercise / conversionCommon Shares | 5,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-104481 · ownership.xml · nonDerivative · entry 1 KASINGER JAMES R. · CIK 0001708172 · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,615 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares remain subject to a lock-up agreement with the underwriters of the Issuer's offering of convertible senior notes due 2031. F2 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 21:35 UTC |
Kulkarni SamarthDirector · Chief Executive Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 19,250 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-104480 · ownership.xml · derivative · entry 3 Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,250 Underlying: Common Shares · 19,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. F1 · kind: These shares remain subject to a lock-up agreement with the underwriters of the Issuer's offering of convertible senior notes due 2031. F2 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. F4 · derivative.exercise_date: This restricted stock unit award was granted on March 10, 2023 with respect to 77,000 Common Shares, with (i) one quarter of the shares vesting on March 10, 2024, (ii) one quarter of the shares vesting on March 10, 2025, (iii) one quarter of the shares vesting on March 10, 2026, and (iv) one quarter of the shares vesting on March 10, 2027. F4 · derivative.expiration_date: This restricted stock unit award was granted on March 10, 2023 with respect to 77,000 Common Shares, with (i) one quarter of the shares vesting on March 10, 2024, (ii) one quarter of the shares vesting on March 10, 2025, (iii) one quarter of the shares vesting on March 10, 2026, and (iv) one quarter of the shares vesting on March 10, 2027. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 21:35 UTC |
Kulkarni SamarthDirector · Chief Executive Officer
|
Exercise / conversionCommon Shares | 19,250 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-104480 · ownership.xml · nonDerivative · entry 1 Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 245,356 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares remain subject to a lock-up agreement with the underwriters of the Issuer's offering of convertible senior notes due 2031. F2 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. Read SEC document |
| February 19, 2026 Filed Feb 20, 2026 22:36 UTC |
Kulkarni SamarthDirector · Chief Executive Officer
|
SaleCommon Shares | 6,967 | $52.58 | $366,324.86 |
DisclosureSEC source: 0001193125-26-061712 · ownership.xml · nonDerivative · entry 2 Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 226,106 F3 · shares: Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person. Read SEC document |
| February 19, 2026 Filed Feb 20, 2026 22:35 UTC |
KASINGER JAMES R.General Counsel and Secretary
|
SaleCommon Shares | 2,112 | $52.58 | $111,048.96 |
DisclosureSEC source: 0001193125-26-061710 · ownership.xml · nonDerivative · entry 2 KASINGER JAMES R. · CIK 0001708172 · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,115 F2 · shares: Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person. Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 22:36 UTC |
Kulkarni SamarthDirector · Chief Executive Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 13,250 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-061712 · ownership.xml · derivative · entry 3 Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 13,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. F1 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. F4 · derivative.exercise_date: This restricted stock unit award was granted on February 18, 2022 with respect to 53,000 Common Shares, with (i) one quarter of the shares vesting on February 18, 2023, (ii) one quarter of the shares vesting on February 18, 2024, (iii) one quarter of the shares vesting on February 18, 2025, and (iv) one quarter of the shares vesting on February 18, 2026. F4 · derivative.expiration_date: This restricted stock unit award was granted on February 18, 2022 with respect to 53,000 Common Shares, with (i) one quarter of the shares vesting on February 18, 2023, (ii) one quarter of the shares vesting on February 18, 2024, (iii) one quarter of the shares vesting on February 18, 2025, and (iv) one quarter of the shares vesting on February 18, 2026. Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 22:36 UTC |
Kulkarni SamarthDirector · Chief Executive Officer
|
Exercise / conversionCommon Shares | 13,250 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-061712 · ownership.xml · nonDerivative · entry 1 Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 233,073 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. F2 · balance_after: Reflects 85,622 shares previously transferred from the Kulkarni 2023 GRAT to the Reporting Person. Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 22:35 UTC |
KASINGER JAMES R.General Counsel and Secretary
|
Exercise / conversionRestricted Stock Units · Derivative | 3,825 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-061710 · ownership.xml · derivative · entry 3 KASINGER JAMES R. · CIK 0001708172 · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 3,825 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. F1 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. F3 · derivative.exercise_date: This restricted stock unit award was granted on February 18, 2022 with respect to 15,300 Common Shares, with (i) one quarter of the shares vesting on February 18, 2023, (ii) one quarter of the shares vesting on February 18, 2024, (iii) one quarter of the shares vesting on February 18, 2025, and (iv) one quarter of the shares vesting on February 18, 2026. F3 · derivative.expiration_date: This restricted stock unit award was granted on February 18, 2022 with respect to 15,300 Common Shares, with (i) one quarter of the shares vesting on February 18, 2023, (ii) one quarter of the shares vesting on February 18, 2024, (iii) one quarter of the shares vesting on February 18, 2025, and (iv) one quarter of the shares vesting on February 18, 2026. Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 22:35 UTC |
KASINGER JAMES R.General Counsel and Secretary
|
Exercise / conversionCommon Shares | 3,825 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-061710 · ownership.xml · nonDerivative · entry 1 KASINGER JAMES R. · CIK 0001708172 · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,227 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. Read SEC document |
| January 22, 2026 Filed Jan 22, 2026 22:55 UTC |
Kulkarni SamarthDirector · Chief Executive Officer
|
SaleCommon Shares | 60,000 | $60.23 | $3,613,800.00 |
DisclosureSEC source: 0001193125-26-019733 · ownership.xml · nonDerivative · entry 3 Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 134,201 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 27, 2025. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.00 to $60.61, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| January 22, 2026 Filed Jan 26, 2026 22:35 UTC |
Prasad RajuChief Financial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 34,972 | $0.00 Strike: $45.15 | $0.00 |
DisclosureSEC source: 0001193125-26-022845 · ownership.xml · derivative · entry 3 Prasad Raju · CIK 0001968317 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 41,667 Underlying: Common Shares · 34,972 shares Expires 2033-03-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option was granted on March 14, 2023 with respect to 100,000 Common Shares, with 25% of the shares vesting on March 14, 2024 and the remaining shares vesting on each monthly anniversary thereafter for a period of 36 months. Read SEC document |
| January 22, 2026 Filed Jan 26, 2026 22:35 UTC |
Prasad RajuChief Financial Officer
|
SaleCommon Shares | 34,972 | $60.19 | $2,104,964.68 |
DisclosureSEC source: 0001193125-26-022845 · ownership.xml · nonDerivative · entry 2 Prasad Raju · CIK 0001968317 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,767 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2025. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.00 to $60.42, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| January 22, 2026 Filed Jan 26, 2026 22:35 UTC |
Prasad RajuChief Financial Officer
|
Exercise / conversionCommon Shares | 34,972 | $45.15 | $1,578,985.80 |
DisclosureSEC source: 0001193125-26-022845 · ownership.xml · nonDerivative · entry 1 Prasad Raju · CIK 0001968317 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 41,739 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 20, 2026 Filed Jan 22, 2026 22:55 UTC |
Kulkarni SamarthDirector · Chief Executive Officer
|
SaleCommon Shares | 8,567 | $52.10 | $446,340.70 |
DisclosureSEC source: 0001193125-26-019733 · ownership.xml · nonDerivative · entry 2 Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 194,201 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 27, 2025. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.00 to $52.45 inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| January 20, 2026 Filed Jan 22, 2026 22:55 UTC |
Kulkarni SamarthDirector · Chief Executive Officer
|
SaleCommon Shares | 21,433 | $51.61 | $1,106,157.13 |
DisclosureSEC source: 0001193125-26-019733 · ownership.xml · nonDerivative · entry 1 Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 202,768 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 27, 2025. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.00 to $51.99, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| January 06, 2026 Filed Jan 8, 2026 22:35 UTC |
Prasad RajuChief Financial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 6,339 | $0.00 Strike: $44.31 | $0.00 |
DisclosureSEC source: 0001193125-26-007875 · ownership.xml · derivative · entry 7 Prasad Raju · CIK 0001968317 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,493 Underlying: Common Shares · 6,339 shares Expires 2033-10-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This option was granted on October 13, 2023 with respect to 13,832 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of November 13, 2023. Read SEC document |
| January 06, 2026 Filed Jan 8, 2026 22:35 UTC |
Prasad RajuChief Financial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 23,361 | $0.00 Strike: $45.15 | $0.00 |
DisclosureSEC source: 0001193125-26-007875 · ownership.xml · derivative · entry 6 Prasad Raju · CIK 0001968317 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 76,639 Underlying: Common Shares · 23,361 shares Expires 2033-03-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option was granted on March 14, 2023 with respect to 100,000 Common Shares, with 25% of the shares vesting on March 14, 2024 and the remaining shares vesting on each monthly anniversary thereafter for a period of 36 months. Read SEC document |
| January 06, 2026 Filed Jan 8, 2026 22:35 UTC |
Prasad RajuChief Financial Officer
|
SaleCommon Shares | 5,763 | $60.21 | $347,009.82 |
DisclosureSEC source: 0001193125-26-007875 · ownership.xml · nonDerivative · entry 5 Prasad Raju · CIK 0001968317 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,767 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2025. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.0000 to $60.4800, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| January 06, 2026 Filed Jan 8, 2026 22:35 UTC |
Prasad RajuChief Financial Officer
|
SaleCommon Shares | 5,004 | $60.00 | $300,240.00 |
DisclosureSEC source: 0001193125-26-007875 · ownership.xml · nonDerivative · entry 4 Prasad Raju · CIK 0001968317 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 12,530 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2025. Read SEC document |
| January 06, 2026 Filed Jan 8, 2026 22:35 UTC |
Prasad RajuChief Financial Officer
|
SaleCommon Shares | 18,933 | $60.18 | $1,139,386.05 |
DisclosureSEC source: 0001193125-26-007875 · ownership.xml · nonDerivative · entry 3 Prasad Raju · CIK 0001968317 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 17,534 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2025. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.0000 to $60.7300, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| January 06, 2026 Filed Jan 8, 2026 22:35 UTC |
Prasad RajuChief Financial Officer
|
Exercise / conversionCommon Shares | 6,339 | $44.31 | $280,881.09 |
DisclosureSEC source: 0001193125-26-007875 · ownership.xml · nonDerivative · entry 2 Prasad Raju · CIK 0001968317 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 36,467 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 06, 2026 Filed Jan 8, 2026 22:35 UTC |
Prasad RajuChief Financial Officer
|
Exercise / conversionCommon Shares | 23,361 | $45.15 | $1,054,749.15 |
DisclosureSEC source: 0001193125-26-007875 · ownership.xml · nonDerivative · entry 1 Prasad Raju · CIK 0001968317 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 30,128 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 22, 2025 Filed Dec 23, 2025 22:33 UTC |
Prasad RajuChief Financial Officer
|
SaleCommon Shares | 1,000 | $56.89 | $56,885.80 |
DisclosureSEC source: 0001193125-25-331162 · ownership.xml · nonDerivative · entry 3 Prasad Raju · CIK 0001968317 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,767 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2025. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.8200 to $56.9900, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| December 22, 2025 Filed Dec 23, 2025 22:33 UTC |
Prasad RajuChief Financial Officer
|
SaleCommon Shares | 5,472 | $56.33 | $308,262.38 |
DisclosureSEC source: 0001193125-25-331162 · ownership.xml · nonDerivative · entry 2 Prasad Raju · CIK 0001968317 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,767 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2025. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.7800 to $56.7700, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| December 22, 2025 Filed Dec 23, 2025 22:33 UTC |
Prasad RajuChief Financial Officer
|
SaleCommon Shares | 3,528 | $55.10 | $194,400.56 |
DisclosureSEC source: 0001193125-25-331162 · ownership.xml · nonDerivative · entry 1 Prasad Raju · CIK 0001968317 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 13,239 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2025. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.7100 to $55.7050, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| December 18, 2025 Filed Dec 22, 2025 22:35 UTC |
Kulkarni SamarthDirector · Chief Executive Officer
|
GiftCommon Shares | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-329010 · ownership.xml · nonDerivative · entry 1 Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 224,201 Read SEC document |
| October 17, 2025 Filed Oct 20, 2025 21:35 UTC |
Kulkarni SamarthDirector · Chief Executive Officer
|
SaleCommon Shares | 50,895 | $67.91 | $3,456,279.45 |
DisclosureSEC source: 0001193125-25-243819 · ownership.xml · nonDerivative · entry 2 Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 254,201 F2 · shares: Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person. Read SEC document |
| October 16, 2025 Filed Oct 20, 2025 21:35 UTC |
Kulkarni SamarthDirector · Chief Executive Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 100,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-25-243819 · ownership.xml · derivative · entry 4 Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Shares · 100,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. F1 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. F3 · derivative.exercise_date: This restricted stock unit award was granted on October 16, 2024 with respect to 400,000 Common Shares, with (i) one quarter of the shares vesting on October 16, 2025, (ii) one quarter of the shares vesting on October 16, 2026, (iii) one quarter of the shares vesting on October 16, 2027, and (iv) one quarter of the shares vesting on October 16, 2028. F3 · derivative.expiration_date: This restricted stock unit award was granted on October 16, 2024 with respect to 400,000 Common Shares, with (i) one quarter of the shares vesting on October 16, 2025, (ii) one quarter of the shares vesting on October 16, 2026, (iii) one quarter of the shares vesting on October 16, 2027, and (iv) one quarter of the shares vesting on October 16, 2028. Read SEC document |
| October 16, 2025 Filed Oct 20, 2025 21:35 UTC |
Kulkarni SamarthDirector · Chief Executive Officer
|
Exercise / conversionCommon Shares | 100,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-25-243819 · ownership.xml · nonDerivative · entry 1 Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 305,096 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. Read SEC document |
| October 14, 2025 Filed Oct 15, 2025 21:35 UTC |
Kulkarni SamarthDirector · Chief Executive Officer
|
SaleCommon Shares | 4,242 | $66.60 | $282,517.20 |
DisclosureSEC source: 0001193125-25-240438 · ownership.xml · nonDerivative · entry 2 Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 205,096 F2 · shares: Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person. Read SEC document |
| October 14, 2025 Filed Oct 15, 2025 21:35 UTC |
KASINGER JAMES R.General Counsel and Secretary
|
SaleCommon Shares | 1,076 | $66.60 | $71,661.60 |
DisclosureSEC source: 0001193125-25-240437 · ownership.xml · nonDerivative · entry 2 KASINGER JAMES R. · CIK 0001708172 · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,402 F3 · shares: Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person. Read SEC document |
| October 13, 2025 Filed Oct 15, 2025 21:35 UTC |
Kulkarni SamarthDirector · Chief Executive Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 8,334 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-25-240438 · ownership.xml · derivative · entry 4 Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,333 Underlying: Common Shares · 8,334 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. F1 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. F3 · derivative.exercise_date: This restricted stock unit award was granted on October 13, 2023 with respect to 25,000 Common Shares, with (i) one third of the shares vesting on October 13, 2024, (ii) one third of the shares vesting on October 13, 2025, and (iii) one third of the shares vesting on October 13, 2026. F3 · derivative.expiration_date: This restricted stock unit award was granted on October 13, 2023 with respect to 25,000 Common Shares, with (i) one third of the shares vesting on October 13, 2024, (ii) one third of the shares vesting on October 13, 2025, and (iii) one third of the shares vesting on October 13, 2026. Read SEC document |
| October 13, 2025 Filed Oct 15, 2025 21:35 UTC |
Kulkarni SamarthDirector · Chief Executive Officer
|
Exercise / conversionCommon Shares | 8,334 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-25-240438 · ownership.xml · nonDerivative · entry 1 Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 209,338 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. Read SEC document |
| October 13, 2025 Filed Oct 15, 2025 21:35 UTC |
KASINGER JAMES R.General Counsel and Secretary
|
Exercise / conversionRestricted Stock Units · Derivative | 2,114 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-25-240437 · ownership.xml · derivative · entry 3 KASINGER JAMES R. · CIK 0001708172 · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,113 Underlying: Common Shares · 2,114 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. F1 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. F4 · derivative.exercise_date: This restricted stock unit award was granted on October 13, 2023 with respect to 6,340 Common Shares, with (i) one third of the shares vesting on October 13, 2024, (ii) one third of the shares vesting on October 13, 2025, and (iii) one third of the shares vesting on October 13, 2026. F4 · derivative.expiration_date: This restricted stock unit award was granted on October 13, 2023 with respect to 6,340 Common Shares, with (i) one third of the shares vesting on October 13, 2024, (ii) one third of the shares vesting on October 13, 2025, and (iii) one third of the shares vesting on October 13, 2026. Read SEC document |
| October 13, 2025 Filed Oct 15, 2025 21:35 UTC |
KASINGER JAMES R.General Counsel and Secretary
|
Exercise / conversionCommon Shares | 2,114 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-25-240437 · ownership.xml · nonDerivative · entry 1 KASINGER JAMES R. · CIK 0001708172 · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,478 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. F2 · balance_after: Includes 635 shares acquired under the CRISPR Therapeutics AG 2016 Employee Stock Purchase Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.